GSK updates its HCP payment policy
GlaxoSmithKline is overturning a blanket ban on payments to doctors promoting its medicines, now allowing the practice under certain circumstances.
Read More
Tag: HCPs
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
